(Q51582543)

7 April 2018

title

Effect of food on the relative bioavailability of oral ganciclovir. (English)

1 reference

7 April 2018

1 reference

Lavelle J

1

1 reference

7 April 2018

Follansbee S

2

1 reference

7 April 2018

Trapnell CB

3

1 reference

7 April 2018

Buhles WC

4

1 reference

7 April 2018

Griffy KG

5

1 reference

7 April 2018

Jung D

6

1 reference

7 April 2018

Dorr A

7

1 reference

7 April 2018

Connor J

8

1 reference

7 April 2018

publication date

1 March 1996

1 reference

7 April 2018

The Journal of Clinical Pharmacology

published in

1 reference

7 April 2018

volume

36

1 reference

7 April 2018

issue

3

1 reference

7 April 2018

page(s)

238-241

1 reference

7 April 2018

Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: a phase I/II study. AIDS Clinical Trials Group, and Cytomegalovirus Cooperative Study Group

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04193.X

Selection of a derivative of the antiviral agent 9-[(1,3-dihydroxy-2-propoxy)-methyl]guanine (DHPG) with improved oral absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04193.X

Interactions affecting drug absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04193.X

Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg/d dosing regimens in human immunodeficiency virus— and cytomegalovirus-seropositive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04193.X

10.1002/J.1552-4604.1996.TB04193.X

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

8690817

1 reference

7 April 2018